BfArM approvals from DCP procedure for Rivastigmin patches granted for Germany, Austria, Romania, Sweden, Slovakia and the Czech Republic

On 28 August 2015, the BfArM granted approvals from DCP procedures for rivastigmin patches at doses 4.6 mg/24 h and 9.5 mg/24 h for Germany, Austria, Romania, Sweden, Slovakia and the Czech Republic.

read more

Patches instead of tablets

So far, most drugs are swallowed. But there has also been talk in the pharmaceutical industry that many medicines can be transported into the body more easily and gently via skin patches – and require much less active ingredient.

read more